About
Non-invasive drug delivery platform technologies
Areas of Focus
Categories
Drug Delivery & FormulationSan Diego & Southern California
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
2,170
By Phase
PHASE3: 2
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05171075Collaborator
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
PHASE3Recruiting
1,020 participants
Started: Sep 27, 2022 · Completed: Feb 28, 2027
NCT05171049Collaborator
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
PHASE3Active, not recruiting
1,150 participants
Started: May 5, 2022 · Completed: Feb 28, 2027
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...